Reference28 articles.
1. Chen YP, Chan ATC, Le QT et al (2019) Nasopharyngeal carcinoma. Lancet 394(10192):64–80
2. Chua MLK, Wee JTS, Hui EP et al (2016) Nasopharyngeal carcinoma. Lancet 387(10022):1012–1024
3. Guo R, Tang LL, Mao YP et al (2019) Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 125(1):79–89
4. Lin JC, Wang WY, Chen KY et al (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350(24):2461–2470
5. Lo YM, Chan LY, Lo KW et al (1999) Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59(6):1188–1191
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献